Your browser doesn't support javascript.
loading
Postmenopausal overweight and breast cancer risk; results from the KARMA cohort.
Klintman, Marie; Rosendahl, Ann H; Randeris, Benjamin; Eriksson, Mikael; Czene, Kamila; Hall, Per; Borgquist, Signe.
Afiliação
  • Klintman M; Division of Oncology, Department of Clinical Sciences Lund, Skåne University Hospital, Lund University, 221 85, Lund, Sweden. marie.klintman@med.lu.se.
  • Rosendahl AH; Division of Oncology, Department of Clinical Sciences Lund, Skåne University Hospital, Lund University, 221 85, Lund, Sweden.
  • Randeris B; Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark.
  • Eriksson M; Karolinska Institute, Stockholm, Sweden.
  • Czene K; Karolinska Institute, Stockholm, Sweden.
  • Hall P; Karolinska Institute, Stockholm, Sweden.
  • Borgquist S; Department of Oncology, Södersjukhuset, Stockholm, Sweden.
Breast Cancer Res Treat ; 196(1): 185-196, 2022 Nov.
Article em En | MEDLINE | ID: mdl-36040641
ABSTRACT

PURPOSE:

To study the risk of incident breast cancer and subtype-specific breast cancer in relation to excess body weight in a contemporary Swedish prospective cohort study, The Karolinska Mammography Project for Risk Prediction of Breast Cancer, KARMA.

METHODS:

A total of 35,412 postmenopausal women attending mammography and included in the KARMA study provided baseline data on body mass index (BMI) and potential confounders. During eight years of follow-up, 822 incident invasive breast cancer cases were identified.

RESULTS:

Women with overweight (BMI ≥ 25-< 30 kg/m2) constituting 34% of the study cohort had an increased risk of incident breast cancer with an adjusted Hazard Ratio (HRadj) 1.19 (95% CI 1.01-1.4). A similar, however, non-significant, association was found for women with obesity (BMI ≥ 30 kg/m2) conferring 13% of the cohort, with a HRadj of 1.19 (95% CI 0.94-1.5). Overweight was associated with risk of node-negative disease (HRadj 1.29, 95% CI 1.06-1.58), whereas obesity was associated with node-positive disease (HRadj 1.64, 95% CI 1.09-2.48). Both overweight and obesity were associated with risk of estrogen receptor positive (ER+) disease (HRadj 1.20, 95% CI 1.00-1.44 and HRadj 1.33, 95% CI 1.03-1.71, respectively), and low-grade tumors (HRadj 1.25, 95% CI 1.02-1.54, and HRadj 1.40, 95% CI 1.05-1.86, respectively). Finally, obesity was associated with ER+HER2 negative disease (HRadj 1.37, 95% CI 1.05-1.78) and similarly luminal A tumors (HRadj 1.43, 95% CI 1.02-2.01).

CONCLUSION:

Overweight and obesity are associated with an increased risk of developing breast cancer, specifically ER+, low-grade, and for obesity, node-positive, high-risk breast cancer indicating a further need for risk communication and preventive programs.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Sobrepeso Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Sobrepeso Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article